Bharat Express DD Free Dish

Sun Pharma

Indian markets extend losses for sixth week as Sensex, Nifty fall amid West Asia tensions, currency volatility and rising crude prices.

Indian drugmakers launch affordable semaglutide injections after patent expiry, expanding access for diabetes and obesity patients across the country.

Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled multiple products from the US market after the regulator flagged manufacturing-related issues.

Indian markets rallied strongly, with Sensex and Nifty closing near record highs amid broad buying.

The Indian stock market ended marginally lower on Thursday after a highly volatile session.

Indian equity indices Sensex and Nifty opened lower on Thursday, influenced by mixed global signals and sectoral performance.

Indian equity market closed lower as investors book profits after Monday’s strong rally, while concerns ongoing US-China trade negotiations.

The Indian stock market opened nearly flat on Friday, with benchmark indices showing little movement amid mixed global trends.

The Sensex closed at 77,330.01, falling 241.30 points or 0.31%. Nifty ended at 23,453.80, down by 78.90 points or 0.34%. Despite the overall decline, the Nifty Bank index rose by 184.25 points or 0.37%, closing at 50,363.80

Indian equity indices ended largely unchanged on Friday as investors awaited a key speech from US Federal Reserve Chairman Jerome Powell.